$1.42-20.5%11月13日 終値
The latest quarter (ended 2026年9月30日) is from Tenon Medical’s earnings press release of 2026年11月12日. It will be replaced by the official quarterly report (10-Q) once Tenon Medical files it.
Just reported
From Tenon Medical, Inc's results release of 2026年11月12日. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
$1.4M
+22% y/y
+12% q/q
Guided
—
No guide given
Actual
-$3.1M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
| 指標 | 終了 3 か月2026年9月30日 | 終了 3 か月2025年9月30日 | 増減 |
|---|---|---|---|
| 売上高合計 | $1.4M | $1.2M | +22.08% |
これは単独四半期の数字であって通年ではありません——このサイトの他の場所の数字は 12 か月を対象としており、はるかに大きくなります。季節性のある事業は両者の間で大きく振れます：ServiceNow は 12 月期に 20 億ドルのフリーキャッシュフローを稼ぎ、6 月期には 5 億ドルです。
比較対象はアナリスト予想ではなく前年同期です。「上振れ」「下振れ」と言うにはコンセンサス予想が必要ですが、それは当方が保有しないライセンスデータであり——間違えるくらいなら載せないほうがましです。
Tenon Medical, Inc reported on 2026年11月12日. We are fetching the call transcript; its summary follows once the transcript is in.
“Third quarter revenue of $1.4 million grew 22% compared to the prior year and 12% sequentially from the second quarter, and we delivered that growth while reducing operating expenses compared to both the third quarter of 2025 and the second quarter of this year,”
発表資料から逐語で引用し、書類が氏名のある人物に帰属させている場合にのみ表示します。
発表は寄り前か引け後に出るため、期間は発表日の前日終値から発表日の翌取引日の終値までとしています。どちらの場合も値動きはこの期間に含まれます。
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the “SI Joint”). The Company has developed The Catamaran ® SI Joint Fusion System (“The Catamaran System”) that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+ ® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon has been focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
発表資料の末尾に記載された、企業自身による説明です。
The quote, the company description and the latest quarter come from Tenon Medical’s earnings press release (an Item 2.02 8-K) filed 2026年11月12日. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. EDGAR で発表資料を読む 株価は分割と配当で調整済みです。